These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35156579)

  • 21. Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.
    Hook V; Funkelstein L; Wegrzyn J; Bark S; Kindy M; Hook G
    Biochim Biophys Acta; 2012 Jan; 1824(1):89-104. PubMed ID: 21925292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach.
    Gan L; Ye S; Chu A; Anton K; Yi S; Vincent VA; von Schack D; Chin D; Murray J; Lohr S; Patthy L; Gonzalez-Zulueta M; Nikolich K; Urfer R
    J Biol Chem; 2004 Feb; 279(7):5565-72. PubMed ID: 14612454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
    Hook VY; Reisine TD
    J Neurosci Res; 2003 Nov; 74(3):393-405. PubMed ID: 14598316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma model.
    Asai M; Yagishita S; Iwata N; Saido TC; Ishiura S; Maruyama K
    FASEB J; 2011 Oct; 25(10):3720-30. PubMed ID: 21746863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells.
    Nopparat C; Boontor A; Panmanee J; Govitrapong P
    Neurotox Res; 2022 Aug; 40(4):1086-1095. PubMed ID: 35648367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.
    Mueller-Steiner S; Zhou Y; Arai H; Roberson ED; Sun B; Chen J; Wang X; Yu G; Esposito L; Mucke L; Gan L
    Neuron; 2006 Sep; 51(6):703-14. PubMed ID: 16982417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Free Radical-Generating System Regulates Amyloid Oligomers: Involvement of Cathepsin B.
    Llorente P; Kristen H; Sastre I; Toledano-Zaragoza A; Aldudo J; Recuero M; Bullido MJ
    J Alzheimers Dis; 2018; 66(4):1397-1408. PubMed ID: 30400084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model.
    Blacher E; Dadali T; Bespalko A; Haupenthal VJ; Grimm MO; Hartmann T; Lund FE; Stein R; Levy A
    Ann Neurol; 2015 Jul; 78(1):88-103. PubMed ID: 25893674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer's disease.
    Xie Z; Meng J; Kong W; Wu Z; Lan F; Narengaowa ; Hayashi Y; Yang Q; Bai Z; Nakanishi H; Qing H; Ni J
    Aging Cell; 2022 Mar; 21(3):e13565. PubMed ID: 35181976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
    Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
    Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.
    Evin G; Cappai R; Li QX; Culvenor JG; Small DH; Beyreuther K; Masters CL
    Biochemistry; 1995 Oct; 34(43):14185-92. PubMed ID: 7578016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.
    Wang YQ; Qu DH; Wang K
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2389-403. PubMed ID: 27338066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil Decreases BACE1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP8 Mouse.
    Orejana L; Barros-Miñones L; Jordan J; Cedazo-Minguez A; Tordera RM; Aguirre N; Puerta E
    J Gerontol A Biol Sci Med Sci; 2015 Jun; 70(6):675-85. PubMed ID: 25063079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.